Genetic, Functional, and Immunogenic Analyses of the


Journal

Journal of bacteriology
ISSN: 1098-5530
Titre abrégé: J Bacteriol
Pays: United States
ID NLM: 2985120R

Informations de publication

Date de publication:
21 03 2023
Historique:
pubmed: 1 3 2023
medline: 24 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

Neisseria meningitidis exhibits a general

Identifiants

pubmed: 36852982
doi: 10.1128/jb.00458-22
pmc: PMC10029716
doi:

Substances chimiques

Bacterial Proteins 0
Polysaccharides 0
Meningococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0045822

Subventions

Organisme : Renee og Bredo Grimsgaard's Foundation
Organisme : Research Council of Norway
ID : 220829

Références

Vaccine. 2005 Jan 11;23(8):977-83
pubmed: 15620470
Vaccine. 2005 Mar 18;23(17-18):2222-7
pubmed: 15755600
Glycobiology. 2017 Sep 1;27(9):888-899
pubmed: 28460017
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14783-8
pubmed: 17804791
Mol Microbiol. 1995 May;16(3):575-86
pubmed: 7565116
PLoS One. 2011 Feb 28;6(2):e17145
pubmed: 21386889
mBio. 2014 Oct 21;5(5):e01974-14
pubmed: 25336458
Infect Immun. 2001 Mar;69(3):1568-73
pubmed: 11179328
Mol Immunol. 2015 Oct;67(2 Pt A):117-30
pubmed: 25697848
PLoS One. 2012;7(4):e35699
pubmed: 22558202
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Nat Rev Microbiol. 2010 Nov;8(11):765-78
pubmed: 20948550
Biochem Biophys Res Commun. 2009 Jan 2;378(1):84-9
pubmed: 19013435
BMC Genomics. 2017 May 25;18(1):407
pubmed: 28545446
PLoS Pathog. 2015 Sep 14;11(9):e1005162
pubmed: 26367394
Vaccine. 2003 Jan 30;21(7-8):734-7
pubmed: 12531351
J Exp Med. 2008 Jun 9;205(6):1423-34
pubmed: 18504306
Clin Vaccine Immunol. 2008 May;15(5):863-71
pubmed: 18337382
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W29-33
pubmed: 23609542
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Mol Microbiol. 2007 Aug;65(3):607-24
pubmed: 17608667
Vaccine. 2009 Jun 24;27 Suppl 2:B78-89
pubmed: 19481311
Bioinformatics. 2018 Jan 15;34(2):292-293
pubmed: 29028899
Vaccines (Basel). 2022 Apr 14;10(4):
pubmed: 35455366
Virulence. 2014 Jan 1;5(1):98-126
pubmed: 24104403
Science. 2000 Mar 10;287(5459):1816-20
pubmed: 10710308
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
Infect Immun. 2001 Jun;69(6):3597-604
pubmed: 11349019
J Infect. 2015 Sep;71(3):326-37
pubmed: 25982025
J Bacteriol. 2012 Sep;194(18):5034-43
pubmed: 22797763
Nat Commun. 2018 Nov 12;9(1):4753
pubmed: 30420631
Infect Immun. 2002 Jul;70(7):3707-13
pubmed: 12065513
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10798-803
pubmed: 15249686
Methods Mol Biol. 2012;799:1-20
pubmed: 21993636
Vaccine. 2009 Jun 24;27 Suppl 2:B112-6
pubmed: 19464093
PLoS Genet. 2019 Dec 23;15(12):e1008532
pubmed: 31869330
J Bacteriol. 2018 Jul 25;200(16):
pubmed: 29555702
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9643-8
pubmed: 21606362
Mol Biol Evol. 2004 Feb;21(2):255-65
pubmed: 14660700
Mol Microbiol. 1995 May;16(3):451-64
pubmed: 7565106
J Bacteriol. 2018 Dec 7;201(1):
pubmed: 30322851
J Bacteriol. 2010 Jun;192(11):2816-29
pubmed: 20363948
Lancet Infect Dis. 2010 Dec;10(12):853-61
pubmed: 21075057
Pathog Dis. 2017 Apr 1;75(3):
pubmed: 28423169
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4447-52
pubmed: 19251655
BMC Genomics. 2014 Dec 18;15:1138
pubmed: 25523208
J Exp Med. 1969 Jun 1;129(6):1327-48
pubmed: 4977281
Glycobiology. 2021 May 3;31(4):477-491
pubmed: 32776107
J Exp Med. 1969 Jun 1;129(6):1307-26
pubmed: 4977280
Nucleic Acids Res. 2021 Jul 2;49(W1):W216-W227
pubmed: 33849055
BMC Genomics. 2012 Jul 24;13:341
pubmed: 22827831
Mol Microbiol. 2014 Nov;94(3):688-99
pubmed: 25213144
Clin Vaccine Immunol. 2007 Apr;14(4):451-63
pubmed: 17301215
Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67
pubmed: 9067649
Nat Rev Microbiol. 2020 Feb;18(2):84-96
pubmed: 31705134
Infect Immun. 1983 Apr;40(1):398-406
pubmed: 6131872
J Immunol. 2016 Dec 1;197(11):4201-4209
pubmed: 27864551
Biochemistry. 2014 Feb 4;53(4):624-38
pubmed: 24383882
J Biol Chem. 2019 Sep 6;294(36):13248-13268
pubmed: 31350337
J Clin Microbiol. 2006 Mar;44(3):861-71
pubmed: 16517868
J Proteome Res. 2012 Dec 7;11(12):5781-93
pubmed: 23030644

Auteurs

Lisbeth M Næss (LM)

Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.

Ingunn S Maugesten (IS)

Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.

Dominique A Caugant (DA)

Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Department of Community Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Afework Kassu (A)

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Abraham Aseffa (A)

Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Bente Børud (B)

Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH